Skip to content

    Recently Viewed


      Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (December 7th, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9th, at the Westin St. Francis in San Francisco, CA. Joaquin Duato, Chairman Elect of the Board and Chief Executive Officer will represent the Company in a session scheduled at 12:45 p.m. (Eastern Time).

      This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at

      The audio webcast replay will be available approximately 48-hrs after the webcast.

      Investor Contact:

      Media Contact:
      Jake Sargent
      (732) 524-1090

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.